Addictive Behaviors

The endogenous cannabinoid system in Individuals with opioid use disorder and healthy: A brain imaging study

Volunteers
Health Professionals

What is the purpose of this trial?

The purpose of the study is to examine the endocannabinoid (eCB) function in individuals with Opioid Use Disorder (OUD) who take methadone or suboxone by measuring cannabinoid receptor 1 (CB1R) availability. Participation includes a screening visit, brain imaging sessions including MRI and PET scan, and two follow-up phone calls. Total estimated compensation is up to $550.

Study Details | OMAR Opioid Use Disorder | ClinicalTrials.gov

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Angelina Contreras

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Anahita Bassir Nia, MD
Assistant Professor of Psychiatry; Research Psychiatrist, VA National Center for PTSD

Sub-Investigators

Last Updated
03/18/2025
Study HIC
#2000033525